Conference abstract · 29 May 2017
Research articlePublished 3 May 2019
Effacing diseases with Antisense Oligonucleotides
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Anti-sense oligonucleotides are short, modified single stranded DNA or RNA that hybridize with target mRNA and inhibit synthesis of encoded peptide. This inhibition is achieved by either degradation of target mRNA by RNase enzyme or by blocking translation. Novel therapeutics are the need of the hour to combat newer diseases. High specificity and lower costs are core issues in the development of novel therapeutic agents. Antisense oligonucleotides meet all these criteria and are also effective in targeting a number of diseases. The presence of formivirsen in the market has provided an impetus for development of new antisense oligonucleotides and several others are in the pipeline. This review focuses on various facets of antisense oligonucliotides.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2016
Branched peptide/DOTAP hybrid systems are efficient antisense oligonucleotide transfection reagents in bacteria
Editorial · 28 Nov 2015
Oral SMAD7 Antisense Oligonucleotide: A Novel Agent for Management of Crohn's Disease
Commentary · 1 Jul 2026
Precision Splice-Modulating Antisense Oligonucleotide Strategy for Spinal Muscular Atrophy Type II Functional Recovery Assessment
Short communication · 2 Jul 2024
Antisense Oligonucleotides Therapy: An Appropriate Approach for Spinal Muscular Atrophy Genetic Management
More from this journal
The newest in Der Pharmacia Lettre.
Article · 28 Feb 2025
Review on: Oral Mucoadhesive Drug Delivery System
Article · 25 Jan 2025
Synthesis and Evaluation for Anti-Infective Activities of 2-Arylidene-1-(4-Methyl-6- Phenylpyrimidin-2-YL) Hydrazides
Article · 22 Jan 2025
Enzyme Inhibitors in Drug Resistance and Overcoming Therapeutic Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Lettre
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “David Banji”
- BylineArticles whose byline prints “Otilia J. F. Banji”
- BylineArticles whose byline prints “Jyothi Pinnapureddy”
